-
The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
J Exp Med. 1968 Feb 1;127(2):371-86
PMID: 4383923
-
C5a induced tracheal contraction: a histamine independent mechanism.
J Immunol. 1980 Jun;124(6):2876-8
PMID: 7373054
-
Generation of leukotrienes by purified human lung mast cells.
J Clin Invest. 1982 Oct;70(4):747-51
PMID: 7119113
-
Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism.
J Immunol. 1985 Jan;134(1):541-7
PMID: 2578053
-
Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease.
Am Rev Respir Dis. 1975 Sep;112(3):423-36
PMID: 240302
-
Purified human basophils and mast cells: current concepts of mediator release.
Eur J Respir Dis Suppl. 1983;128 (Pt 1):53-61
PMID: 6578086
-
Gross and ultrastructural observations on lesions produced by intradermal injection of human C3a in man.
Am J Pathol. 1970 Oct;61(1):13-23
PMID: 4099033
-
Arachidonic acid metabolism in purified human lung mast cells.
J Immunol. 1984 Apr;132(4):1972-9
PMID: 6199420
-
Cyclooxygenase metabolites in human lung anaphylaxis: airway vs. parenchyma.
J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):589-95
PMID: 6813301
-
Human skin mast cells: their dispersion, purification, and secretory characterization.
J Immunol. 1987 Feb 1;138(3):861-7
PMID: 2433332
-
Induction of acute inflammatory reactions in lung following intrapulmonary instillation of preformed chemotactic peptides and purified complement components.
Chest. 1979 Feb;75(2 Suppl):259-62
PMID: 436469
-
Studies of human C5a as a mediator of inflammation in normal human skin.
J Clin Invest. 1985 Feb;75(2):486-95
PMID: 2982914
-
Heterogeneity of human mast cells.
J Immunol. 1983 Oct;131(4):1936-41
PMID: 6194221
-
Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Proc Natl Acad Sci U S A. 1981 Mar;78(3):1833-7
PMID: 6940191
-
Mast cell heterogeneity: derivation and function, with emphasis on the intestine.
J Allergy Clin Immunol. 1982 Dec;70(6):407-12
PMID: 6183305
-
Human lung mast cells: purification and characterization.
J Immunol. 1982 Dec;129(6):2662-7
PMID: 6183340
-
Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
J Immunol. 1984 Jun;132(6):2862-7
PMID: 6373920
-
Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.
J Immunol. 1979 Oct;123(4):1847-57
PMID: 479602
-
Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a.
J Exp Med. 1981 Jan 1;153(1):136-53
PMID: 6161204
-
Anaphylatoxin-mediated contraction of guinea pig lung strips: a nonhistamine tissue response.
J Immunol. 1981 Jun;126(6):2258-61
PMID: 6164725
-
Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function.
Immunopharmacology. 1980 Jun;2(3):201-19
PMID: 6254906
-
Cutaneous responses to human C 3 anaphylatoxin in man.
Clin Exp Immunol. 1972 May;11(1):13-20
PMID: 4114148
-
Cytochemical variation of mast cells in the skin of the rat.
Arch Dermatol Res. 1977 Mar 25;258(1):69-80
PMID: 140629
-
Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells.
J Immunol. 1983 May;130(5):2357-62
PMID: 6187853
-
Rapid micromeasurement of neutrophil exocytosis.
Inflammation. 1978 Jun;3(2):129-35
PMID: 216633
-
Structure and function of the anaphylatoxins.
Springer Semin Immunopathol. 1984;7(2-3):193-219
PMID: 6387982
-
Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.
J Exp Med. 1973 May 1;137(5):1109-23
PMID: 4121926
-
Lung inflammation induced by complement-derived chemotactic fragments in the alveolus.
Lab Invest. 1980 May;42(5):547-58
PMID: 7382429
-
Release of histamine from rat mast cells by the complement peptides C3a and C5a.
Immunology. 1975 Jun;28(6):1067-80
PMID: 48505
-
Complement-induced histamine release from human basophils. II. Mechanism of the histamine release reaction.
J Immunol. 1976 Mar;116(3):639-46
PMID: 56398
-
Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation.
Int Arch Allergy Appl Immunol. 1981;64(1):25-41
PMID: 7450901
-
Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma.
Am Rev Respir Dis. 1981 Oct;124(4):402-6
PMID: 6170242
-
STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN.
J Exp Med. 1964 Oct 1;120:507-30
PMID: 14212116
-
Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
Am J Pathol. 1983 Jul;112(1):48-60
PMID: 6859228
-
Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution.
Life Sci. 1982 Nov 8;31(19):2093-103
PMID: 6960222
-
Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
J Immunol. 1982 May;128(5):2247-52
PMID: 6174625
-
Basophil counting with a new staining method using alcian blue.
Blood. 1975 Aug;46(2):279-86
PMID: 49201
-
Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4.
Proc Natl Acad Sci U S A. 1985 Oct;82(19):6632-6
PMID: 2995976